These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30577793)

  • 1. Integrating proteomic and phosphoproteomic data for pathway analysis in breast cancer.
    Ren J; Wang B; Li J
    BMC Syst Biol; 2018 Dec; 12(Suppl 8):130. PubMed ID: 30577793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer subtyping from plasma proteins.
    Zhang F; Chen JY
    BMC Med Genomics; 2013; 6 Suppl 1(Suppl 1):S6. PubMed ID: 23369492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
    Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
    J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoproteomic analysis reveals PAK2 as a therapeutic target for lapatinib resistance in HER2-positive breast cancer cells.
    Chang Y; Park KH; Lee JE; Han KC
    Biochem Biophys Res Commun; 2018 Oct; 505(1):187-193. PubMed ID: 30243723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-free proteomic analysis of breast cancer molecular subtypes.
    Panis C; Pizzatti L; Herrera AC; Corrêa S; Binato R; Abdelhay E
    J Proteome Res; 2014 Nov; 13(11):4752-72. PubMed ID: 25221861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection.
    Raj-Kumar PK; Lin X; Liu T; Sturtz LA; Gritsenko MA; Petyuk VA; Sagendorf TJ; Deyarmin B; Liu J; Praveen-Kumar A; Wang G; McDermott JE; Shukla AK; Moore RJ; Monroe ME; Webb-Robertson BM; Hooke JA; Fantacone-Campbell L; Mostoller B; Kvecher L; Kane J; Melley J; Somiari S; Soon-Shiong P; Smith RD; Mural RJ; Rodland KD; Shriver CD; Kovatich AJ; Hu H
    Breast Cancer Res; 2024 May; 26(1):76. PubMed ID: 38745208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.
    Gökmen-Polar Y; True JD; Vieth E; Gu Y; Gu X; Qi GD; Mosley AL; Badve SS
    PLoS One; 2018; 13(10):e0204658. PubMed ID: 30278072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein biomarkers for subtyping breast cancer and implications for future research.
    Mueller C; Haymond A; Davis JB; Williams A; Espina V
    Expert Rev Proteomics; 2018 Feb; 15(2):131-152. PubMed ID: 29271260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteogenomics connects somatic mutations to signalling in breast cancer.
    Mertins P; Mani DR; Ruggles KV; Gillette MA; Clauser KR; Wang P; Wang X; Qiao JW; Cao S; Petralia F; Kawaler E; Mundt F; Krug K; Tu Z; Lei JT; Gatza ML; Wilkerson M; Perou CM; Yellapantula V; Huang KL; Lin C; McLellan MD; Yan P; Davies SR; Townsend RR; Skates SJ; Wang J; Zhang B; Kinsinger CR; Mesri M; Rodriguez H; Ding L; Paulovich AG; Fenyö D; Ellis MJ; Carr SA;
    Nature; 2016 Jun; 534(7605):55-62. PubMed ID: 27251275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative proteomic and phosphoproteomic profiling of invasive micropapillary breast carcinoma.
    Chen X; Lin Y; Jin X; Zhang W; Guo W; Chen L; Chen M; Li Y; Fu F; Wang C
    J Proteomics; 2022 Apr; 257():104511. PubMed ID: 35139397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.
    Tang W; Zhou M; Dorsey TH; Prieto DA; Wang XW; Ruppin E; Veenstra TD; Ambs S
    Genome Med; 2018 Dec; 10(1):94. PubMed ID: 30501643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated proteomic and phosphoproteomic analysis for characterization of colorectal cancer.
    Zhu H; Li Y; Guo J; Feng S; Ge H; Gu C; Wang M; Nie R; Li N; Wang Y; Wang H; Zhong J; Qian X; He G
    J Proteomics; 2023 Mar; 274():104808. PubMed ID: 36596410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of SYK Signaling Networks Reveals the Potential Molecular Determinants of Its Tumor-Promoting and Suppressing Functions.
    Buffard M; Naldi A; Freiss G; Deckert M; Radulescu O; Coopman PJ; Larive RM
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstructing phosphorylation signalling networks from quantitative phosphoproteomic data.
    Invergo BM; Beltrao P
    Essays Biochem; 2018 Oct; 62(4):525-534. PubMed ID: 30072490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative phosphoproteomic analysis of a human tumor metastasis model using a label-free quantitative approach.
    Xie X; Feng S; Vuong H; Liu Y; Goodison S; Lubman DM
    Electrophoresis; 2010 Jun; 31(11):1842-52. PubMed ID: 20446291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
    Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoproteomic analysis of Her2/neu signaling and inhibition.
    Bose R; Molina H; Patterson AS; Bitok JK; Periaswamy B; Bader JS; Pandey A; Cole PA
    Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9773-8. PubMed ID: 16785428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Proteomic and Phosphoproteomic Responses to Signaling Network Perturbations Reveals Functional Pathway Organizations in Yeast.
    Li J; Paulo JA; Nusinow DP; Huttlin EL; Gygi SP
    Cell Rep; 2019 Nov; 29(7):2092-2104.e4. PubMed ID: 31722220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoproteomics reveals network rewiring to a pro-adhesion state in annexin-1-deficient mammary epithelial cells.
    Alli-Shaik A; Wee S; Lim LHK; Gunaratne J
    Breast Cancer Res; 2017 Dec; 19(1):132. PubMed ID: 29233185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.